
Rare lung disease treated with monoclonal antibody
A proof-of-concept study led by a scientist at the University of Florida suggests a monoclonal antibody that targets a master regulator of inflammation, called NAMPT, could offer much-needed treatment for acute respiratory distress syndrome (ARDS). In the study, a monoclonal antibody treatment called ALT-100 was used in… Read More


